Pirfenidone

Details

Files

Generic Name:

Pirfenidone

Project Status:

Complete

Therapeutic Area:

Idiopathic pulmonary fibrosis

Manufacturer:

InterMune Canada Inc.

Call for patient/clinician input open:

October 5, 2012

Brand Name:

Esbriet

Project Line:

Reimbursement Review

Project Number:

SR0292-000

Call for patient/clinician input closed:

October 26, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Pulmonary fibrosis (idiopathic, mild to moderate)

Recommendation Type:

Do not list

Final Recommendation:

April 18, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 5, 2012